Dr. Reddy’s Laboratories shares jump over 1% as European Commission approves biosimilar AVT03
The European Commission’s approval of AVT03 enables Dr. Reddy’s and Alvotech to market the biosimilar widely in Europe, potentially enhancing revenue...
Read Full Article →